Pdb62 - Cost-Effectiveness Analysis of Empagliflozin in Japan Based on Results From the Subgroup Analysis of Asian Patients in the Empa-Reg Outcome Trial

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.767
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb63 - Cost-Effectiveness Analysis of Empagliflozin Treatment in Patients With Type 2 Diabetes and Chronic Heart Failure Based on Subgroup of Empa-Reg Outcome in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect?

International Journal of General Medicine
Medicine
2017English

Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Ce1 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2017English

DECLARE-TIMI 58 Trial in the Context of EMPA-REG OUTCOME and CANVAS

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Consistent Cardiovascular (CV) Benefit of Empagliflozin Over the Spectrum of CV Risk Factor Control in EMPA-REG OUTCOME

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

EMPA-REG OUTCOME: The Endocrinologist's Point of View

American Journal of Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy